Dementia as the most common presentation of cortical-basal ganglionic degeneration

被引:160
作者
Grimes, DA
Lang, AE
Bergeron, CB
机构
[1] Morton & Gloria Shulman Movement Disorder Ctr, Toronto, ON, Canada
[2] Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
关键词
cortical-basal ganglionic degeneration; dementia; frontotemporal dementia;
D O I
10.1212/WNL.53.9.1969
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the clinical presentations and dominant symptoms of patients with postmortem proven cortical-basal ganglionic degeneration (CBGD) from one neuropathology center. Background: CBGD is a rare but increasingly recognized condition with clinical and pathologic features that continue to evolve. Attempts have been made to develop clinical criteria to enhance the specificity of diagnosis, but it is not clear what proportion of patients harboring CBGD disease present in the "classical" fashion versus other presentations. Previous large-case series that emphasize a parietal/perceptual-motor presentation may be biased because the cases mainly originate from movement disorder centers. Methods: Thirteen cases of pathologically confirmed CBGD with sufficient clinical data were identified from a single neuropathology center between 1981 and 1996. Results: Before death, only 4 of the 13 patients had a clinical diagnosis of CBGD, 6 had a clinical diagnosis of Alzheimer's disease (AD), 1 had AD and parkinsonism, and 2 had an atypical dementia of the frontotemporal type. Nine of 13 cases had early dementia. Conclusions: Dementia was the most common presentation of CBGD in this study. Despite the best efforts to define criteria to enhance the specificity of a diagnosis of CBGD, it is becoming clear that the clinical syndrome that accompanies this disease is quite varied. Unfortunately, patients fulfilling classical diagnostic criteria may represent a minority of those with this pathologic diagnosis.
引用
收藏
页码:1969 / 1974
页数:6
相关论文
共 28 条
[1]  
Bergeron C, 1998, BRAIN PATHOL, V8, P355
[2]  
BERGERON C, 1996, ANN NEUROL, V40, P72
[3]  
BOEVE BF, 1997, BRAIN PATHOL, V7
[4]   CORTICAL DEGENERATION WITH SWOLLEN CHROMATOLYTIC NEURONS - ITS RELATIONSHIP TO PICKS DISEASE [J].
CLARK, AW ;
MANZ, HJ ;
WHITE, CL ;
LEHMANN, J ;
MILLER, D ;
COYLE, JT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (03) :268-284
[5]   PICKS DISEASE - HISTOLOGICAL AND CLINICAL CORRELATIONS [J].
CONSTANT.J ;
RICHARD, J ;
TISSOT, R .
EUROPEAN NEUROLOGY, 1974, 11 (04) :208-217
[6]   TAU, UBIQUITIN, AND ALPHA-BETA-CRYSTALLIN IMMUNOHISTOCHEMISTRY DEFINE THE PRINCIPAL CAUSES OF DEGENERATIVE FRONTOTEMPORAL DEMENTIA [J].
COOPER, PN ;
JACKSON, M ;
LENNOX, G ;
LOWE, J ;
MANN, DMA .
ARCHIVES OF NEUROLOGY, 1995, 52 (10) :1011-1015
[7]   Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration [J].
Feany, MB ;
Mattiace, LA ;
Dickson, DW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (01) :53-67
[8]  
FEANY MB, 1995, AM J PATHOL, V146, P1388
[9]   Neurodegenerative disorders with extensive tau pathology: A comparative study and review [J].
Feany, MB ;
Dickson, DW .
ANNALS OF NEUROLOGY, 1996, 40 (02) :139-148
[10]   Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: Case report and review [J].
Ikeda, K ;
Akiyama, H ;
Iritani, S ;
Kase, K ;
Arai, T ;
Niizato, K ;
Kuroki, N ;
Kosaka, K .
ACTA NEUROPATHOLOGICA, 1996, 92 (05) :534-539